0001410384-20-000035.txt : 20200226
0001410384-20-000035.hdr.sgml : 20200226
20200226164924
ACCESSION NUMBER: 0001410384-20-000035
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200224
FILED AS OF DATE: 20200226
DATE AS OF CHANGE: 20200226
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Offerdahl James
CENTRAL INDEX KEY: 0001490198
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36350
FILM NUMBER: 20656545
MAIL ADDRESS:
STREET 1: 11501 DOMAIN DRIVE
STREET 2: SUITE 200
CITY: AUSTIN
STATE: TX
ZIP: 78758
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Q2 Holdings, Inc.
CENTRAL INDEX KEY: 0001410384
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-PREPACKAGED SOFTWARE [7372]
IRS NUMBER: 202706637
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 13785 RESEARCH BOULEVARD
STREET 2: SUITE 150
CITY: Austin
STATE: TX
ZIP: 78750
BUSINESS PHONE: 512-275-0072
MAIL ADDRESS:
STREET 1: 13785 RESEARCH BOULEVARD
STREET 2: SUITE 150
CITY: Austin
STATE: TX
ZIP: 78750
FORMER COMPANY:
FORMER CONFORMED NAME: CBG Holdings, Inc.
DATE OF NAME CHANGE: 20120103
FORMER COMPANY:
FORMER CONFORMED NAME: CBG Holdings Inc
DATE OF NAME CHANGE: 20070821
4
1
wf-form4_158275374626448.xml
FORM 4
X0306
4
2020-02-24
0
0001410384
Q2 Holdings, Inc.
QTWO
0001490198
Offerdahl James
13785 RESEARCH BLVD.
SUITE 150
AUSTIN
TX
78750
1
0
0
0
Common Stock
2020-02-24
4
M
0
5480
13
A
13873
D
Common Stock
2020-02-24
4
M
0
4520
24.89
A
18393
D
Common Stock
2020-02-24
4
S
0
10000
82.06
D
8393
D
Stock Option (right to buy)
13.0
2020-02-24
4
M
0
5480
0
D
2014-04-19
2024-03-19
Common Stock
5480.0
0
D
Stock Option (right to buy)
24.89
2020-02-24
4
M
0
4520
0
D
2015-07-09
2022-06-09
Common Stock
4520.0
502
D
Shares sold pursuant to Reporting Person's 10b5-1 Trading Plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $80.95 to $83.35 inclusive. Reporting Person undertakes to provide to Q2 Holdings, Inc., any security holder of Q2 Holdings, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
The option grant vested and became exercisable in equal monthly installments over 36 months beginning on April 19, 2014.
The option grant vested and became exercisable in equal monthly installments over 36 months beginning on July 9, 2015.
/s/ M. Scott Kerr, attorney-in-fact
2020-02-26